Friday, April 24, 2026
29.7
C
Bengaluru
Hot topics
Indian Pharma October 2025 Sales Data
1. Overall Market Growth & Trends (IPM Key Highlights):
Robust...
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends...
Pharma Digital Transformation – Leadership challenges
“Real digital transformation occurs when courageous leaders align goals...
MedicinMan Steps into Year Five
Articles by K. Hariram, Daxesh Patel, Gopal Kishore, Amit Jain, Sunil Bajaj and Vivek Hattangadi
Healthcare Marketing in the Covid-19 Era
How should healthcare business leaders (pharma, devices, diagnostics, disposables...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
The Semaglutide Shift: From Blockbuster to Commodity
Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
Ritesh Desai has joined Standard Chartered India as Executive...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
The Semaglutide Shift: From Blockbuster to Commodity
Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
Ritesh Desai has joined Standard Chartered India as Executive...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
The Semaglutide Shift: From Blockbuster to Commodity
Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
Ritesh Desai has joined Standard Chartered India as Executive...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
The Semaglutide Shift: From Blockbuster to Commodity
Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
Ritesh Desai has joined Standard Chartered India as Executive...
Hot topics
Covid-19 Impact on Indian Pharma Revenues, Field Force, Doctors – Sunil Attavar, CMD Group Pharma
This is the third and final part of MedicinMan...
IMS Health Market Reflection Report for August 2016
The Indian Pharmaceutical Market (IPM) was valued at Rs. 10,426 crores in the month of August 2016 clocking a strong 18% growth over same period last year (SPLY). This was the second consecutive month where the IPM crossed the 10,000 crore mark.
Astra Zeneca Tops Indian Pharma in New Introductions 2024
Analysis of Indian Pharmaceutical Market (IPM) – 2024
This data...
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
April 14, 2025
India’s pharmaceutical industry, a global powerhouse, sends...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
The Semaglutide Shift: From Blockbuster to Commodity
Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
Ritesh Desai has joined Standard Chartered India as Executive...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
The Semaglutide Shift: From Blockbuster to Commodity
Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
Ritesh Desai has joined Standard Chartered India as Executive...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
The Semaglutide Shift: From Blockbuster to Commodity
Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
Ritesh Desai has joined Standard Chartered India as Executive...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
The Semaglutide Shift: From Blockbuster to Commodity
Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
In 1989, oncology in India was not a business...
Ritesh Desai has joined Standard Chartered India as Executive Director
Ritesh Desai has joined Standard Chartered India as Executive...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap
The Semaglutide Shift: From Blockbuster to Commodity
Why the $50...
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
In 1989, oncology in India was not a business...
Newsletter
Get important news delivered directly to your inbox and stay connected!